These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 28370332

  • 21. Plasma N-terminal pro-brain natriuretic peptide concentrations before and after pericardiocentesis in dogs with cardiac tamponade secondary to spontaneous pericardial effusion.
    Baumwart RD, Hanzlicek AS, Lyon SD, Lee PM.
    J Vet Cardiol; 2017 Oct; 19(5):416-420. PubMed ID: 28988688
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of echocardiography and cardiac biomarker concentrations in dogs with gastric dilatation volvulus.
    Aona BD, Rush JE, Rozanski EA, Cunningham SM, Sharp CR, Freeman LM.
    J Vet Emerg Crit Care (San Antonio); 2017 Nov; 27(6):631-637. PubMed ID: 28960715
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects.
    van Kimmenade RR, Januzzi JL, Bakker JA, Houben AJ, Rennenberg R, Kroon AA, Crijns HJ, van Dieijen-Visser MP, de Leeuw PW, Pinto YM.
    J Am Coll Cardiol; 2009 Mar 10; 53(10):884-90. PubMed ID: 19264247
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Seemingly healthy 71-year-old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT-proBNP: report from the ULSAM study.
    Venge P, Arnlöv J, Zethelius B.
    Scand J Clin Lab Invest; 2009 Mar 10; 69(3):418-24. PubMed ID: 19221927
    [Abstract] [Full Text] [Related]

  • 28. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):91-7. PubMed ID: 16386670
    [Abstract] [Full Text] [Related]

  • 29. Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT.
    Ascher SB, Berry JD, Katz R, de Lemos JA, Bansal N, Garimella PS, Hallan SI, Wettersten N, Jotwani VK, Killeen AA, Ix JH, Shlipak MG.
    Am J Kidney Dis; 2024 May 03; 83(5):615-623.e1. PubMed ID: 37992982
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Utility of N-terminal pro-brain natriuretic peptide for assessing hemodynamic significance of patent ductus arteriosus in dogs undergoing ductal repair.
    Hariu CD, Saunders AB, Gordon SG, Norby B, Miller MW.
    J Vet Cardiol; 2013 Sep 03; 15(3):197-204. PubMed ID: 23933478
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [N-terminal proBNP and high sensivity cardiac troponin I concentrations in haemodialysis patients].
    Rumenjak V, Brajković-Bralić M, Varlaj-Knobloch V, Orsanić-Brcić D, Brajković I, Marinković D, Knobloch M.
    Acta Med Croatica; 2011 Oct 03; 65 Suppl 3():36-40. PubMed ID: 23120813
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with pulmonic stenosis.
    Kobayashi K, Hori Y, Chimura S.
    J Vet Med Sci; 2014 Jun 03; 76(6):827-31. PubMed ID: 24561377
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R, Hashimoto Y, Senmaru T, Tanaka M, Ushigome E, Yamazaki M, Fukui M.
    Endocr Metab Immune Disord Drug Targets; 2018 Jun 03; 18(6):590-595. PubMed ID: 29697035
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.